Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary infections complicating hematological disorders.

Corrado Girmenia1, Pietro Martino

  • 1Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy.

Seminars in Respiratory and Critical Care Medicine
|November 4, 2005
PubMed
Summary

Pulmonary infections are a major risk for patients with hematological disorders. Diagnosis and treatment are challenging due to non-specific symptoms and patient conditions, requiring tailored antimicrobial strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same author

Key Indications for Passive Immune Prophylaxis Against SARS-CoV-2 Infection in Malignant Hematological Disorders: An Analytic Hierarchy Process by an Ad Hoc Italian Expert Panel.

Vaccines·2026
Same author

Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell and in Solid Organ Transplantation: Updated Recommendations by the GITMO, SITO, SIMIT, and AMCLI Italian Societies.

Clinical transplantation·2025
Same author

The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis.

Open forum infectious diseases·2025
Same author

Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024

Area of Science:

  • Hematology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pulmonary infections are a significant cause of illness and death in patients with hematological disorders.
  • Diagnosing pneumonitis in these patients is complex due to subtle clinical signs and non-specific radiographic findings.
  • Impaired inflammatory responses and conditions like thrombocytopenia can hinder diagnostic procedures.

Purpose of the Study:

  • To review the challenges in diagnosing and managing pulmonary diseases in immunocompromised patients with hematological disorders.
  • To highlight the importance of prevention and empirical antimicrobial therapy.
  • To discuss the limitations of a single therapeutic algorithm for pulmonary infiltrates.

Main Methods:

  • Review of literature on pulmonary infections in hematological disorders.

Related Experiment Videos

  • Discussion of diagnostic challenges and therapeutic approaches.
  • Emphasis on empirical broad-spectrum antimicrobial administration.

    • Main Results:

    • Pulmonary infections are a leading cause of infectious morbidity and mortality in hematological patients.
    • Diagnosis is often difficult, requiring invasive procedures which may not be feasible.
    • No universal treatment algorithm exists due to diverse causes and patient conditions.

    Conclusions:

    • Aggressive prevention and empirical broad-spectrum antimicrobials are key initial strategies.
    • Treatment must be guided by clinical and microbiological findings.
    • Individualized therapeutic approaches are necessary for pulmonary infiltrates in immunocompromised hematological patients.